BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28556023)

  • 1. Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series.
    Leon-Castillo A; Chrisinger JSA; Panse G; Samdani RT; Ingram DR; Ravi V; Prieto VG; Wang WL; Lazar AJ
    J Cutan Pathol; 2017 Aug; 44(8):692-697. PubMed ID: 28556023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of eight melanocytic and neural crest-associated markers in a well-characterised series of 124 malignant peripheral nerve sheath tumours (MPNST): useful to distinguish MPNST from melanoma?
    Gaspard M; Lamant L; Tournier E; Valentin T; Rochaix P; Terrier P; Ranchere-Vince D; Coindre JM; Filleron T; Le Guellec S
    Histopathology; 2018 Dec; 73(6):969-982. PubMed ID: 30137667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX11, SOX10 and MITF Gene Interaction: A Possible Diagnostic Tool in Malignant Melanoma.
    Beleaua MA; Jung I; Braicu C; Milutin D; Gurzu S
    Life (Basel); 2021 Mar; 11(4):. PubMed ID: 33801642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of five antibodies as markers in the diagnosis of melanoma in cytologic preparations.
    Sheffield MV; Yee H; Dorvault CC; Weilbaecher KN; Eltoum IA; Siegal GP; Fisher DE; Chhieng DC
    Am J Clin Pathol; 2002 Dec; 118(6):930-6. PubMed ID: 12472287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
    Orchard GE
    Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness.
    Shon W; Jenkins SM; Ross DT; Seitz RS; Beck RA; Ring BZ; Okuno SH; Gibson LE; Folpe AL
    J Cutan Pathol; 2011 Dec; 38(12):961-6. PubMed ID: 22050093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
    Fanburg-Smith JC; Furlong MA; Childers EL
    Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas.
    Roma AA; Magi-Galluzzi C; Zhou M
    Arch Pathol Lab Med; 2007 Jan; 131(1):122-5. PubMed ID: 17227112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors.
    Boyle JL; Haupt HM; Stern JB; Multhaupt HA
    Arch Pathol Lab Med; 2002 Jul; 126(7):816-22. PubMed ID: 12088451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
    Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
    Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM; Prieto VG; Elder DE; Duncan LM
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous epithelioid angiosarcoma: a clinicopathologic study of 13 cases of a rare neoplasm occurring outside the setting of conventional angiosarcomas and with predilection for the limbs.
    Suchak R; Thway K; Zelger B; Fisher C; Calonje E
    Am J Surg Pathol; 2011 Jan; 35(1):60-9. PubMed ID: 21164288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous angiosarcoma arising in massive localized lymphedema of the morbidly obese: a report of five cases and review of the literature.
    Shon W; Ida CM; Boland-Froemming JM; Rose PS; Folpe A
    J Cutan Pathol; 2011 Jul; 38(7):560-4. PubMed ID: 21518378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases.
    Ohsawa M; Naka N; Tomita Y; Kawamori D; Kanno H; Aozasa K
    Cancer; 1995 Jun; 75(12):2867-74. PubMed ID: 7773935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers.
    Zavala-Pompa A; Folpe AL; Jimenez RE; Lim SD; Cohen C; Eble JN; Amin MB
    Am J Surg Pathol; 2001 Jan; 25(1):65-70. PubMed ID: 11145253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
    de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
    Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunophenotypic differences between uveal and cutaneous melanomas.
    Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
    Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.